Literature DB >> 33679721

Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells.

Wei Liang1, Napoleone Ferrara2.   

Abstract

Cells of the innate immune system are a major component of the tumor microenvironment. They play complex and multifaceted roles in the regulation of cancer initiation, growth, metastasis and responses to therapeutics. Innate immune cells like neutrophils and macrophages are recruited to cancerous tissues by chemotactic molecules released by cancer cells and cancer-associated stromal cells. Once they reach the tumor, they can be instructed by a network of proteins, nucleic acids and metabolites to exert protumoral or antitumoral functions. Altered iron metabolism is a feature of cancer. Epidemiological studies suggest that increased presence of iron and/or iron binding proteins is associated with increased risks of cancer development. It has been shown that iron metabolism is involved in shaping the immune landscapes in inflammatory/infectious diseases and cancer-associated inflammation. In this article, we will dissect the contribution of macrophages and neutrophils to dysregulated iron metabolism in malignant cells and its impact on cancer growth and metastasis. The mechanisms involved in regulating the actions of macrophages and neutrophils will also be discussed. Moreover, we will examine the effects of iron metabolism on the phenotypes of innate immune cells. Both iron chelating and overloading agents are being explored in cancer treatment. This review highlights alternative strategies for management of iron content in cancer cells by targeting the iron donation and modulation properties of macrophages and neutrophils in the tumor microenvironment.
Copyright © 2021 Liang and Ferrara.

Entities:  

Keywords:  cancer; iron; macrophage; metastasis; neutrophils

Year:  2021        PMID: 33679721      PMCID: PMC7928394          DOI: 10.3389/fimmu.2020.626812

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  119 in total

1.  Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value.

Authors:  Sanja Srdelić Mihalj; Ivana Kuzmić-Prusac; Sandra Zekić-Tomaš; Ivana Šamija-Projić; Vesna Čapkun
Journal:  Histopathology       Date:  2015-02-16       Impact factor: 5.087

2.  The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells.

Authors:  Alessio Iannetti; Francesco Pacifico; Renato Acquaviva; Alfonso Lavorgna; Elvira Crescenzi; Carlo Vascotto; Gianluca Tell; Anna Maria Salzano; Andrea Scaloni; Emilia Vuttariello; Gennaro Chiappetta; Silvestro Formisano; Antonio Leonardi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

3.  Six-transmembrane epithelial antigen of the prostate-1 plays a role for in vivo tumor growth via intercellular communication.

Authors:  Takashi Yamamoto; Yasuaki Tamura; Jun-Ichi Kobayashi; Kenjirou Kamiguchi; Yoshihiko Hirohashi; Akihiro Miyazaki; Toshihiko Torigoe; Hiroko Asanuma; Hiroyoshi Hiratsuka; Noriyuki Sato
Journal:  Exp Cell Res       Date:  2013-08-02       Impact factor: 3.905

4.  Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.

Authors:  Dewei Ye; Kangmin Yang; Shufei Zang; Zhuofeng Lin; Hau-Tak Chau; Yudong Wang; Jialiang Zhang; Junping Shi; Aimin Xu; Shaoqiang Lin; Yu Wang
Journal:  J Hepatol       Date:  2016-06-04       Impact factor: 25.083

5.  Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.

Authors:  Michael K Kiessling; Claus D Klemke; Marcin M Kaminski; Ioanna E Galani; Peter H Krammer; Karsten Gülow
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

Review 6.  Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy.

Authors:  Irena Adkins; Jitka Fucikova; Abhishek D Garg; Patrizia Agostinis; Radek Špíšek
Journal:  Oncoimmunology       Date:  2015-01-07       Impact factor: 8.110

7.  The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma.

Authors:  Claudia Rehwald; Matthias Schnetz; Anja Urbschat; Christina Mertens; Julia K Meier; Rebekka Bauer; Patrick Baer; Sofia Winslow; Frederik C Roos; Klaus Zwicker; Arnaud Huard; Andreas Weigert; Bernhard Brüne; Michaela Jung
Journal:  Br J Cancer       Date:  2019-11-27       Impact factor: 7.640

8.  Local iron homeostasis in the breast ductal carcinoma microenvironment.

Authors:  Oriana Marques; Graça Porto; Alexandra Rêma; Fátima Faria; Arnaud Cruz Paula; Maria Gomez-Lazaro; Paula Silva; Berta Martins da Silva; Carlos Lopes
Journal:  BMC Cancer       Date:  2016-03-05       Impact factor: 4.430

9.  Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages.

Authors:  Milene Costa da Silva; Michael O Breckwoldt; Francesca Vinchi; Margareta P Correia; Ana Stojanovic; Carl Maximilian Thielmann; Michael Meister; Thomas Muley; Arne Warth; Michael Platten; Matthias W Hentze; Adelheid Cerwenka; Martina U Muckenthaler
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561

10.  Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer.

Authors:  Yoshiro Itatani; Takamasa Yamamoto; Cuiling Zhong; Alfredo A Molinolo; Jane Ruppel; Priti Hegde; M Mark Taketo; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-19       Impact factor: 11.205

View more
  4 in total

Review 1.  Myeloid cell-targeted therapies for solid tumours.

Authors:  Sangeeta Goswami; Swetha Anandhan; Deblina Raychaudhuri; Padmanee Sharma
Journal:  Nat Rev Immunol       Date:  2022-06-13       Impact factor: 53.106

2.  Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.

Authors:  Johanna M Buschhaus; Shrila Rajendran; Brock A Humphries; Alyssa C Cutter; Ayşe J Muñiz; Nicholas G Ciavattone; Alexander M Buschhaus; Tatiana Cañeque; Zeribe C Nwosu; Debashis Sahoo; Avinash S Bevoor; Yatrik M Shah; Costas A Lyssiotis; Pradipta Ghosh; Max S Wicha; Raphaël Rodriguez; Gary D Luker
Journal:  Oncogene       Date:  2022-06-22       Impact factor: 8.756

Review 3.  Natural killer cells: a promising immunotherapy for cancer.

Authors:  Junfeng Chu; Fengcai Gao; Meimei Yan; Shuang Zhao; Zheng Yan; Bian Shi; Yanyan Liu
Journal:  J Transl Med       Date:  2022-05-23       Impact factor: 8.440

Review 4.  Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.

Authors:  Lanqing Li; Xiaoqiang Wang; Haiying Xu; Xianqiong Liu; Kang Xu
Journal:  Front Mol Biosci       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.